methyl 3-fluoropyrrolidine-3-carboxylate hydrochloride
98%
- Product Code: 64544
CAS:
1375473-59-8
| Molecular Weight: | 183.61 g./mol | Molecular Formula: | C₆H₁₁ClFNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various bioactive molecules. Its structure, featuring a fluorinated pyrrolidine ring, makes it valuable for designing drugs targeting central nervous system disorders, such as anxiety, depression, and neurodegenerative diseases. The fluorine atom enhances metabolic stability and bioavailability, while the ester group allows for further chemical modifications. It is also employed in the preparation of peptide mimetics and enzyme inhibitors, contributing to the development of novel therapeutic agents. Additionally, its hydrochloride salt form improves solubility, facilitating its use in experimental formulations and drug delivery systems.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White Solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £214.86 |
+
-
|
| 0.250 | 10-20 days | £402.58 |
+
-
|
| 1.000 | 10-20 days | £723.74 |
+
-
|
methyl 3-fluoropyrrolidine-3-carboxylate hydrochloride
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various bioactive molecules. Its structure, featuring a fluorinated pyrrolidine ring, makes it valuable for designing drugs targeting central nervous system disorders, such as anxiety, depression, and neurodegenerative diseases. The fluorine atom enhances metabolic stability and bioavailability, while the ester group allows for further chemical modifications. It is also employed in the preparation of peptide mimetics and enzyme inhibitors, contributing to the development of novel therapeutic agents. Additionally, its hydrochloride salt form improves solubility, facilitating its use in experimental formulations and drug delivery systems.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :